CD Biosynsis uses synthetic biology tools to help customers achieve heterologous expression of ethylene-forming enzymes in microorganisms and optimization of ethylene synthesis metabolic pathways. Based on our established synthetic biology platform, we are committed to exploring commercial applications of ethylene biosynthesis with our collaborators.
Ethylene is an important plant hormone that is involved in regulating the development and maturation process of plants. Ethylene is widely used in industry and consumed in huge quantities. Currently, ethylene is mainly produced through petroleum cracking. However, in the process of petrochemical production of ethylene, each ton of ethylene produced releases 1.5-3.0 tons of carbon dioxide, which causes serious environmental pollution. Compared with traditional ethylene production, ethylene biosynthesis has the advantages of low input, high product purity, low carbon and environmental protection. Therefore, the development of ethylene biosynthesis pathways has become a hot topic in synthetic biology research.
Figure 1. Biosynthetic pathways of ethylene synthetic. (Cui Y, et al., 2022)
We used metabolic engineering tools to optimize the ethylene biosynthesis pathway to improve ethylene production.
We use tools such as gene editing to regulate the expression of genes that play an important role in ethylene production to improve the efficiency of ethylene biosynthesis.
CD Biosynsis can construct plasmids containing genes encoding ethylene-forming enzymes to convert non-ethylene producing microorganisms into ethylene-producing microorganisms. We can help customers construct recombinant plasmids expressing ethylene-forming enzymes, and analyze the ability of microorganisms to synthesize ethylene. The following are microorganisms that have successfully achieved heterologous expression of ethylene-forming enzymes. If you would like to inquire about other microbial chassis for ethylene synthesis, please contact us directly. We look forward to working with you to develop new microbial chassis for ethylene production.
|Escherichia coli||Saccharomyces cerevisiae||Trichoderma viride|
|Trichoderma reesei||Synechocystis sp.|
Photoautotrophic production of ethylene is not affected by the carbohydrate starting material. We are able to achieve heterologous expression of ethylene-forming enzymes in photosynthetic cyanobacteria. Unlike other microorganisms that produce ethylene, photosynthetic cyanobacteria undergo a series of reactions driven by solar energy to produce ethylene directly from CO2.
We are able to use genetic engineering tools to knock out relevant genes that play a disruptive role in ethylene biosynthesis based on a metabolic retargeting strategy. We help our customers select microbial strains with higher efficiency in ethylene synthesis through microbial metabolic pathway modifications.
CD Biosynsis can develop tailored tools and customized approaches to harness the power of synthetic biology to drive ethylene production and meet the needs of customers in a variety of industries.
As a rapidly growing synthetic biology company, CD Biosynsis is committed to helping our customers meet the growing and evolving demand for bio-based chemical production. All of our deliverables will undergo a rigorous quality testing process to ensure the quality and reliability and can be delivered on time. If you are interested in our services or have any further questions, please do not hesitate to contact us.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.